Roche warned that President Trump's executive order on drug pricing threatens its planned $50 billion investment in the ...

President Donald Trump's plans to dramatically slash drug prices for Americans could make Swiss pharmaceutical giant Roche cancel major investments in ...

Aide to RFK Jr. says White House is pushing for global price parity on GLP-1 drugs for weight loss. Read more here.

US President Trump has taken aim at Europe for undercharging for medicine. But raising prices in Europe would face strong ...

Trump's tariffs are meant to promote investment in domestic manufacturing, but experts told Scripps News the reality of ...

France's Sanofi is the latest European pharma group to promise a big capital investment programme on manufacturing and R&D in ...

It’s not immediately clear what the scope of these operations will be — beyond manufacturing at both Sanofi and “partners ...

The recent executive order signed by U.S. President Donald Trump poses a threat to Roche's $50 billion investment plan in the United States, the pharmaceutical giant stated on Wednesday. The directive ...